Mesenchymal Stem Cells (MSCs): A Novel Therapy for Type 2 Diabetes
Although plenty of drugs are currently available for type 2 diabetes mellitus (T2DM), a subset of patients still failed to restore normoglycemia. Recent studies proved that symptoms of T2DM patients who are unresponsive to conventional medications could be relieved with mesenchymal stem/stromal cell...
Saved in:
Main Authors: | Shuang Gao, Yuanyuan Zhang, Kaini Liang, Ran Bi, Yanan Du |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2022/8637493 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE EFFECT OF PLATELET RICH PLASMA ON MESENCHYMAL STEM CELLs (MSCs) DIFFERENTIATION INTO CHONDROBLAST
by: Dwikora Novembri Utomo, et al.
Published: (2019-12-01) -
Mesenchymal Stem Cells as a Prospective Therapy for the Diabetic Foot
by: Qinan Wu, et al.
Published: (2016-01-01) -
Targeting ferroptosis: opportunities and challenges of mesenchymal stem cell therapy for type 1 diabetes mellitus
by: Le Dai, et al.
Published: (2025-02-01) -
CYTOTOXIC EFFECT OF FREEZE DRIED BOVINE CARTILAGE POWDER AND PLATELET RICH PLASMA (PRP) TO MESENCHYMAL STEM CELL (MSCs)
by: Dwikora Novembri Utomo, et al.
Published: (2019-12-01) -
GFAPβ and GFAPδ Isoforms Expression in Mesenchymal Stem Cells, MSCs Differentiated Towards Schwann-like, and Olfactory Ensheathing Cells
by: Nidia Jannette Carrillo González, et al.
Published: (2025-01-01)